CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.9% | 43.9% | 50.3% | 32.4% | 52.3% | 56.6% | 50.0% | 42.5% | 48.6% | 21.9% | 29.4% | 39.9% | 34.9% | |
| 8.6% | 8.3% | 8.3% | 9.6% | 7.7% | 7.3% | 6.7% | 6.7% | 6.5% | 6.3% | 6.2% | 6.5% | 6.4% | |
| 3.3% | 3.7% | 3.8% | 8.4% | 3.6% | 3.4% | 3.6% | 4.1% | 5.2% | 3.8% | 3.7% | 4.2% | 4.2% | |
| 0.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -15.8% | -3.5% | 6.9% | -8.8% | 7.0% | 20.6% | 3.1% | -5.0% | 0.6% | -26.7% | -9.9% | -8.7% | -11.2% | |
| 0.0% | 0.1% | 2.1% | 0.2% | 0.0% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | -90.4% | -34.7% | -0.2% | 0.0% | -0.2% | -0.1% | – | 0.0% | – | 0.0% | 0.0% | – | |
| -0.1% | 0.0% | -0.4% | -0.3% | 0.0% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | -16.6% | -9.8% | -6.7% | |
| -0.2% | -9.9% | -0.6% | 143.2% | 0.9% | -4.6% | 3.1% | 2.2% | 0.6% | 3.1% | -16.8% | -8.6% | -5.5% | |
| 30.7% | -56.3% | 15.1% | 175.4% | 53.2% | 51.8% | 53.0% | 44.6% | 49.2% | 25.0% | 12.6% | 31.3% | 29.3% | |
| 30.9% | 43.9% | 48.2% | 32.2% | 52.3% | 56.4% | 49.9% | 42.5% | 48.6% | 21.9% | 29.4% | 39.9% | 34.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.